Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
City of Hope Medical Center
Washington University School of Medicine
Thomas Jefferson University
Baptist Health South Florida
Columbia University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Columbia University
Seagen Inc.
Stanford University
National Institutes of Health Clinical Center (CC)
University Hospital Tuebingen
University of Chicago
Targazyme, Inc.
University of Kentucky
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center